Sangamo Therapeutics, Inc.
|
 |
||||||||
|
 |
  |
 |
|
|
||
 |
 |
 
 |
return to message board, top of board |
Re: Sanofi says ST400(**)(4) Proof of concept study read-out in Beta thalassemia H1 2021 BIVV003(**)(4) Proof of concept study read-out in Sickle Cell Disease H1 2021Having put a lot of slides together I wonder about the fact that both are at the bottom of the list. As best as I can tell the list is not alphabetic or in order of development. ego |
||||||||||||
|
|
return to message board, top of board |
| Msg # | Subject | Author | Recs | Date Posted |
| 154541 | Re: Sanofi says ST400(**)(4) Proof of concept study read-out in Beta thalassemia H1 2021 BIVV003(**)(4) Proof of concept study read-out in Sickle Cell Disease H1 2021 | SFV | 0 | 1/22/2021 1:15:04 PM |
| 154542 | Re: Sanofi says ST400(**)(4) Proof of concept study read-out in Beta thalassemia H1 2021 BIVV003(**)(4) Proof of concept study read-out in Sickle Cell Disease H1 2021 | NewJeans | 15 | 1/22/2021 1:20:19 PM |
| 154543 | Re: Sanofi says ST400(**)(4) Proof of concept study read-out in Beta thalassemia H1 2021 BIVV003(**)(4) Proof of concept study read-out in Sickle Cell Disease H1 2021 | sangamo | 2 | 1/22/2021 1:22:16 PM |
